Skip to main content

Cardiology Update India 2020

Mumbai, India
Type of event
on site


Dear collegues

It is a pleasure to announce the 2nd Indo-European Cardiology Update to be held on September 19th - 20th, 2020. Based on the tremendous success and wide acclaim for the Cardiology Update 2019 in Mumbai, the organizers have assembled a truly spectacular scientific program for this year. The joint Indo-European collaboration in the field of cardiology from prevention to management of coronary disease and heart failure is an important avenue to decrease the chronic disease burden in India.

The proposed scientific agenda includes the latest trends in hypertension, Lipid disorders and diabetes based on evidence and the most recent guidelines which are of paramount importance to the physicians in clinical practice. The course will further include state-of-art presentations by eminent Indian and European faculty known for their clinical expertise in the most common cardiac conditions.

We are confident that the Indo-European Cardiology Update 2020 will be yet another milestone in professional education and in the annals of preventive cardiology. The attendees will gain additional clinical tools in the early identification of cardiovascular risk factors and in the management of cardiovascular disease in the community.

Best wishes and kind regards,

Thomas F. Lüscher and C. Venkata S. Ram

In partnrship with


In collaboration with







Day - 1 Saturday, September 19th, 2020

Times listed in India time

Welcome Address Session: London 12:30 pm, Zurich 1:30 pm & India: 5:00 pm
5:00 pm Welcome, Introduction C.Venkata S.Ram, Hyderabad, India
5:10 pm Greetings from Zurich Heart House Thomas F. Lüscher, London & Zurich


Session 1: Prevention
Chairs: Ulrich Laufs, Leipzig, Germany & P.P. Mohanan, Thissur, India
5:20 pm A personalized approach towards prevention Thomas F. Lüscher, London & Zurich
5:40 pm Hypertension 2020: Salient Features C. Venkata S. Ram, Hyderabad, India
6:00 pm Dyslipidaemia: Treatment targets and novel
strategies (new ESC Guidelines)
Ulrich Laufs, Leipzig, Germany
6:20 pm Optimal pharmacotherapy to achieve lipid
target levels in clinical practice
J.P.S. Sawhney, New Delhi, India
6:40 pm Panel discussion, Q and A Audience Participation


Session 2: Cardiovascular Disease: An Overview
Chairs: Bernard Gersh, Rochester, USA & C.K. Ponde, Mumbai, India
7:15pm Management of chronic coronary syndromes after the
ISCHEMIA trial:Do we need to change the current ESC
and US Guidelines?
Bernard Gersh, Rochester, USA
7:35pm Dual antiplatelet therapy: Scientific evidence and a practical guide Ajit Mullasari, Chennai, India
7:55pm What is the current status and evidence for aspirin usage in
the prevention of vascular disease
P.P. Mohanan, Thrissur, India
8:15pm Panel discussion, Q and A Audience Participation
Session End Time: London 3:45 pm, Zurich 4:45 pm & India 8:15 pm


Day - 2 Sunday, September 20th, 2020

Times listed in India time

Welcome Address Session: London 12:30 pm, Zurich 1:30 pm & India: 5:00 pm
Session 3: Cardiovascular Disease: Hot Topics
Chairs: Jamshed Dalal, Mumbai, India & Lars Sondergaard, Copenhagen, Denmark
5:00pm Important and interesting cardiac arrhythmias in
clinical practice: A tutorial
Calambur Narasimhan, Hyderabad, India
5:20pm Management of Aortic valve disease in 2020 Lars Soendergaard, Copenhagen, Denmark
5:40pm Non-invasive technique to detect coronary artery disease Rishi Sethi, Lucknow, India
6:00pm Panel discussion, Q and A Audience Participation


Session 4: Cardio-Metabolic Disorders, Heart Failure
Chairs: Yash Lokhandawala, Mumbai, India & Martin Cowie, London, UK
6:30pm Importance of additional cardiovascular risk reduction in
diabetes: The role of statins
Nagaraj Desai, Bangalore, India
6:50pm Heart failure and diabetes: Mechanisms and new treatment
options(ESC Guidelines)
Ulrich Laufs, Leipzig, Germany
7:10pm Adjunctive and complementary therapeutic approaches to
decrease the overall cardiovascular disease risk in the community
Rajeev Agarwala, Meerut, India
7:30pm Rationale behind combination lipid lowering therapy in high risk patients Jamshed Dalal, Mumbai, India
7:50pm Panel discussion, Q and A Audience Participation
8:20pm Concluding remarks and way forward Thomas F. Lüscher, London & Zurich
C.Venkata S.Ram, Hyderabad, India
Session End Time: London 3:50 pm, Zurich 4:50 pm & India 8:20 pm